NeuroOne Medical Reports Q3 2026 Earnings
$NMTC · NEUROONE MEDICAL TECHNOLOGIES CorpResearch Summary
AI-generated summary of this SEC filing
NeuroOne Medical Reports Q3 2026 Earnings
What Happened
NeuroOne Medical Technologies Corporation (NMTC) announced its financial results for the third fiscal quarter ended June 30, 2026. The company issued a press release dated August 13, 2026 reporting those quarterly results and furnished that press release as Exhibit 99.1 to its Form 8-K (filed Aug 13, 2026) under Item 2.02 (Results of Operations and Financial Condition).
Key Details
- Filing date: August 13, 2026 (Form 8-K filed with the SEC).
- Quarter covered: third fiscal quarter ended June 30, 2026.
- Press release: furnished as Exhibit 99.1 to the Form 8-K (dated Aug 13, 2026).
- The 8-K notifies investors the company reported quarterly results; the filing itself does not reproduce detailed financial line items (those are in the press release).
Why It Matters
This 8-K signals that NeuroOne has released its latest quarterly earnings and related financial information—items that can affect revenue expectations, profitability outlook, and the stock price. Retail investors should read the attached press release (Exhibit 99.1) and any subsequent SEC filings (e.g., Form 10-Q) for the specific revenue, net income/loss, cash position, and management commentary before making investment decisions.